Myeloma Proteins and the Clinical Response to Melphalan Therapy
- 16 April 1965
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 148 (3668), 376-377
- https://doi.org/10.1126/science.148.3668.376
Abstract
Objective improvement after therapy with melphalan occurred in all patients producing only Bence Jones kappa proteins, in half of the patients with myeloma serum proteins, and in none of those producing only Bence Jones lambda proteins.Keywords
This publication has 5 references indexed in Scilit:
- Subclasses of Human γ 2 -Globulin Based on Differences in the Heavy Polypeptide ChainsScience, 1964
- CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERSThe Journal of Experimental Medicine, 1962
- THE ANTIGENIC STRUCTURE OF THE POLYPEPTIDE CHAINS OF HUMAN γ-GLOBULINThe Journal of Experimental Medicine, 1962
- THE NATURE OF BENCE-JONES PROTEINSThe Journal of Experimental Medicine, 1962
- Multiple-Myeloma proteins.I. Immunological studiesCancer, 1956